Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Scenarios and speculation

<< Previous

Bullboard Posts

Next >>

Comment by Hydroqcon Feb 04, 2023 10:04pm

194 Views

Post# 35267300

RE:RE:RE:RE:RE:RE:RE:RE:RE:Scenarios and speculation

Dumbuck, when you say ''we are tired'', are you talking about your multiple personnality?
Must be pretty confusing to make some sense in that bucklehead.

If you really have any share, you should make some real DD.

Or you could spend your investing money in a lottery, no need of DD, and you could circle the date on your calendar.

I have never been, in my 15 years of shareholders, more confident to be ITNTDF.

GLTA

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec